Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,974.00
Bid: 2,972.00
Ask: 2,974.00
Change: 24.00 (0.81%)
Spread: 2.00 (0.067%)
Open: 2,947.00
High: 2,979.00
Low: 2,934.00
Prev. Close: 2,950.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 Jul 2014 16:42

RNS Number : 6640M
3i Group PLC
17 July 2014
 



3i GROUP PLC ANNUAL GENERAL MEETING

 

Thursday 17 July 2014

 

The Annual General Meeting for 2014 of 3i Group plc was held on Thursday 17 July 2014 at The Queen Elizabeth II Conference Centre,

Broad Sanctuary, Westminster, London SW1P 3EE.

 

A poll was held on each of the resolutions proposed, which were passed as follows:

 

Ordinary Resolutions

 

Votes

For 

Percentage of votes for

Votes Against

Percentage of votes against

Total votes cast

% of ISC voted

Votes Withheld

1. THAT the Company's Accounts for the year to 31 March 2014, the Directors' report and the Auditors' report on those Accounts, on the Directors' report and on the auditable part of the Directors' remuneration report be and they are hereby received and considered

 

715,409,211

99.94

396,035

0.06

715,805,246

73.64%

616,444

2. THAT the Directors' remuneration report (other than the part containing the Directors' remuneration policy) in the form set out in the Company's Annual report and accounts for the year ended 31 March 2014 be and it is hereby approved

 

690,675,950

98.53

10,279,207

1.47

700,955,157

72.11%

15,466,533

3. THAT the Directors' remuneration policy in the form set out in the Directors' remuneration report in the Company's Annual report and accounts for the year ended to 31 March 2014 be and it is hereby approved

 

701,059,781

98.10

13,563,200

1.90

714,622,981

73.51

1,798,709

4. THAT a final dividend of 13.3p per ordinary share be and it is hereby declared, payable to those shareholders whose names appeared on the Register of Members at close of business on 20 June 2014

 

715,689,774

99.98

155,743

0.02

715,845,517

73.64%

576,173

5. THAT Mr J P Asquith be and he is hereby reappointed as a Director of the Company

 

707,127,062

98.80

8,622,506

1.20

715,749,568

73.63%

672,122

6. THAT Mr S A Borrows be and he is hereby reappointed as a Director of the Company

 

689,089,539

96.27

26,688,014

3.73

715,777,553

73.63%

644,137

7. THAT Mr A R Cox be and he is hereby reappointed as a Director of the Company

 

713,305,672

99.66

2,440,963

0.34

715,746,635

73.63%

675,055

8. THAT Mr D A M Hutchison be and he is hereby reappointed as a Director of the Company

 

715,452,767

99.96

294,264

0.04

715,747,031

73.63%

674,659

9. THAT Sir Adrian Montague be and he is hereby reappointed as a Director of the Company

 

706,180,630

99.56

3,091,136

0.44

709,271,766

72.96%

7,149,924

10. THAT Ms M G Verluyten be and she is hereby reappointed as a Director of the Company

 

713,225,331

99.65

2,481,472

0.35

715,706,803

73.63%

714,887

11. THAT Mrs J S Wilson be and she is hereby reappointed as a Director of the Company

 

713,889,312

99.74

1,825,104

0.26

715,714,416

73.63%

707,274

12. THAT Ernst & Young LLP be and they are hereby reappointed as Auditors of the Company to hold office until the conclusion of the next General Meeting at which Accounts are laid before the Members

 

706,528,610

99.60

2,845,003

0.40

709,373,613

72.97%

7,048,077

13. THAT the Board be and it is hereby authorised to fix the Auditors' remuneration

 

714,657,977

99.84

1,145,387

0.16

715,803,364

73.63%

618,326

14. THAT the revised Investment Policy set out in Appendix 2 to the Notice of Annual General Meeting dated 19 May 2014 be approved

 

712,479,151

99.94

437,730

0.06

712,916,881

73.34

3,504,809

15. To renew the authority to incur political expenditure

 

687,683,796

96.08

28,066,924

3.92

715,750,720

73.63%

670,970

16. To renew the Directors' authority to allot shares

 

698,249,685

97.67

16,639,093

2.33

714,888,778

73.54%

1,532,912

 

 

 

 

 

 

 

 

Special Resolutions

 

 

 

 

 

 

 

 

17. To renew the Directors' authority to allot shares for cash

 

715,205,206

99.93

508,133

0.07

715,713,339

73.63%

708,351

18. To renew the Company's authority to purchase its own ordinary shares

 

715,263,049

99.92

558,906

0.08

715,821,955

73.64%

599,735

19. THAT a General Meeting other than an Annual General Meeting may be called on not less than 14 clear days' notice

 

661,188,011

92.37

54,653,374

7.63

715,841,385

73.64%

580,305

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEDLFFZDFZBBF
Date   Source Headline
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.